Mesoblast Other Current Liabilities

Mesoblast (MESO) currently reports a other current liabilities of $32M as of December 2025. That compares with $41M in the prior-year period — down 22.4% year over year. Use the charts on this page to explore Mesoblast's other current liabilities history and peer comparisons.

Mesoblast's other current liabilities decreased from $41M to $32M — a 22.4% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Mesoblast reported $32M in other current liabilities as of December 2025. That compares with $41M in the prior-year period — down 22.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $32M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Mesoblast, and consider following MESO for alerts when major investors trade the stock.

Mesoblast is classified in the Healthcare sector. On other current liabilities, it currently shows $32M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MESO with unrelated industries.